Clinical Trial Update: PRISM for Depression and Anxiety in Young Adults With Cancer [NA]

View source ↗

Summary

PRISM is a trial evaluating depression and anxiety in young adults with cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Cancer
• Desmoid Tumor
• Major Depressive Disorder

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Cancer Diagnosis, Non-Metastatic Neoplasm | NA | Status: COMPLETED